Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients
<p>Abstract</p> <p>Background</p> <p>In hemodialysis, extracorporeal blood flow (Qb) recommendation is 300–500 mL/min. To achieve the best Qb, we based our prescription on dynamic arterial line pressure (DALP).</p> <p>Methods</p> <p>This prospect...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-11-01
|
Series: | BMC Nephrology |
Online Access: | http://www.biomedcentral.com/1471-2369/9/15 |
id |
doaj-442ee582887b4676b8ef80c47b1512b1 |
---|---|
record_format |
Article |
spelling |
doaj-442ee582887b4676b8ef80c47b1512b12020-11-25T00:04:47ZengBMCBMC Nephrology1471-23692008-11-01911510.1186/1471-2369-9-15Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patientsRosales LauraFlores NellyDe-La-Cruz GuadalupeMagaña SalvadorHerrera–Felix Juan PMariscal AlfonsoMora-Bravo Franklin GFranco MarthaPérez-Grovas Héctor<p>Abstract</p> <p>Background</p> <p>In hemodialysis, extracorporeal blood flow (Qb) recommendation is 300–500 mL/min. To achieve the best Qb, we based our prescription on dynamic arterial line pressure (DALP).</p> <p>Methods</p> <p>This prospective study included 72 patients with catheter Group 1 (G1), 1877 treatments and 35 arterio-venous (AV) fistulae Group 2 (G2), 1868 treatments. The dialysis staff was trained to prescribe Qb sufficient to obtain DALP between -200 to -250 mmHg. We measured ionic clearance (IK: mL/min), access recirculation, DALP (mmHg) and Qb (mL/min). Six prescription zones were identified: from an optimal A zone (Qb > 400, DALP -200 to -250) to zones with lower Qb E (Qb < 300, DALP -200 to -250) and F (Qb < 300, DALP > -199).</p> <p>Results</p> <p>Treatments distribution in A was 695 (37%) in G1 vs. 704 (37.7%) in G2 (<it>P </it>= 0.7). In B 150 (8%) in G1 vs. 458 (24.5%) in G2 (<it>P </it>< 0.0001). Recirculation in A was 10.0% (Inter quartile rank, IQR 6.5, 14.2) in G1 vs. 9.8% (IQR 7.5, 14.1) in G2 (<it>P </it>= 0.62). IK in A was 214 ± 34 (G1) vs. 213 ± 35 (G2) (<it>P </it>= 0.65). IK Anova between G2 zones was: A vs. C and D (<it>P </it>< 0.000001). Staff prescription adherence was 81.3% (G1) vs. 84.1% (G2) (<it>P </it>= 0.02).</p> <p>Conclusion</p> <p>In conclusion, an optimal Qb can de prescribed with DALP of -200 mmHg. Staff adherence to DLAP treatment prescription could be reached up to 81.3% in catheters and 84.1% in AV fistulae.</p> http://www.biomedcentral.com/1471-2369/9/15 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rosales Laura Flores Nelly De-La-Cruz Guadalupe Magaña Salvador Herrera–Felix Juan P Mariscal Alfonso Mora-Bravo Franklin G Franco Martha Pérez-Grovas Héctor |
spellingShingle |
Rosales Laura Flores Nelly De-La-Cruz Guadalupe Magaña Salvador Herrera–Felix Juan P Mariscal Alfonso Mora-Bravo Franklin G Franco Martha Pérez-Grovas Héctor Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients BMC Nephrology |
author_facet |
Rosales Laura Flores Nelly De-La-Cruz Guadalupe Magaña Salvador Herrera–Felix Juan P Mariscal Alfonso Mora-Bravo Franklin G Franco Martha Pérez-Grovas Héctor |
author_sort |
Rosales Laura |
title |
Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients |
title_short |
Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients |
title_full |
Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients |
title_fullStr |
Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients |
title_full_unstemmed |
Arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients |
title_sort |
arterial line pressure control enhanced extracorporeal blood flow prescription in hemodialysis patients |
publisher |
BMC |
series |
BMC Nephrology |
issn |
1471-2369 |
publishDate |
2008-11-01 |
description |
<p>Abstract</p> <p>Background</p> <p>In hemodialysis, extracorporeal blood flow (Qb) recommendation is 300–500 mL/min. To achieve the best Qb, we based our prescription on dynamic arterial line pressure (DALP).</p> <p>Methods</p> <p>This prospective study included 72 patients with catheter Group 1 (G1), 1877 treatments and 35 arterio-venous (AV) fistulae Group 2 (G2), 1868 treatments. The dialysis staff was trained to prescribe Qb sufficient to obtain DALP between -200 to -250 mmHg. We measured ionic clearance (IK: mL/min), access recirculation, DALP (mmHg) and Qb (mL/min). Six prescription zones were identified: from an optimal A zone (Qb > 400, DALP -200 to -250) to zones with lower Qb E (Qb < 300, DALP -200 to -250) and F (Qb < 300, DALP > -199).</p> <p>Results</p> <p>Treatments distribution in A was 695 (37%) in G1 vs. 704 (37.7%) in G2 (<it>P </it>= 0.7). In B 150 (8%) in G1 vs. 458 (24.5%) in G2 (<it>P </it>< 0.0001). Recirculation in A was 10.0% (Inter quartile rank, IQR 6.5, 14.2) in G1 vs. 9.8% (IQR 7.5, 14.1) in G2 (<it>P </it>= 0.62). IK in A was 214 ± 34 (G1) vs. 213 ± 35 (G2) (<it>P </it>= 0.65). IK Anova between G2 zones was: A vs. C and D (<it>P </it>< 0.000001). Staff prescription adherence was 81.3% (G1) vs. 84.1% (G2) (<it>P </it>= 0.02).</p> <p>Conclusion</p> <p>In conclusion, an optimal Qb can de prescribed with DALP of -200 mmHg. Staff adherence to DLAP treatment prescription could be reached up to 81.3% in catheters and 84.1% in AV fistulae.</p> |
url |
http://www.biomedcentral.com/1471-2369/9/15 |
work_keys_str_mv |
AT rosaleslaura arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients AT floresnelly arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients AT delacruzguadalupe arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients AT maganasalvador arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients AT herrerafelixjuanp arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients AT mariscalalfonso arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients AT morabravofrankling arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients AT francomartha arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients AT perezgrovashector arteriallinepressurecontrolenhancedextracorporealbloodflowprescriptioninhemodialysispatients |
_version_ |
1725427983605301248 |